IP Library Granted Patent US 9,200,328
Granted Patent B1
US 9,200,328 · App. 13/830,325 · Granted Dec 1, 2015

Methods and kits for diagnosing the prognosis of cancer patients

Inventors: Elaine Lynette Wilson (New York, NY); Liliana Ossowski (Forest Hills, NY); Phillip Ross Smith (New York, NY)
Assignee: NEW YORK UNIVERSITY
C12Q1/6886G01N33/6893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,200,328
App. No.
13/830,325
Granted
Dec 1, 2015
Kind
B1
Abstract

The prognosis of a cancer patient can be determined by analyzing the modulation of expression of specified genes in the tumor tissue. Genes uniquely up-regulated in adult stem cells that can reconstitute the tissue of the tumor are analyzed for up-regulation in the patient's tumor. Up-regulation of a plurality of such genes in the tumor is an indication of good prognosis. Genes uniquely up-regulated in fetal stem cells are analyzed for up-regulation in the patient's tumor. Up-regulation of a plurality of such genes in the tumor are an indication of a poor prognosis. Specific genes are disclosed, the modulation of which, in a patient's prostate cancer tumor, will serve as an indication of prognosis. Patients with a good prognosis are subjected to watchful waiting. Patients with a poor prognosis are aggressively treated. Kits are provided containing a set of affinity reagents that specifically detect expression of the various genes.

Claims (39)

1. A kit for determining expression of at least seven genes selected from the group consisting of JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, comprising:

a set of affinity reagents to specifically detect expression of said at least seven genes, wherein said set of affinity reagents contains fewer than 2,501 affinity reagents; and

a substrate on which each of said affinity reagents are physically immobilized at a particular predefined position.

2. The kit of claim 1 , further comprising at least one signal producing system that, used in conjunction with at least one of said affinity reagents, generates a signal if said affinity reagent binds to a marker of expression of the gene for which said reagent is specific, the presence of said signal indicating expression of said gene or the level of said signal correlating to the level of expression of said gene.

3. A kit in accordance with claim 1 , wherein said set of affinity reagents further includes affinity reagents to detect expression of control genes.

4. A kit in accordance with claim 1 , for detecting all of the genes JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, wherein said set of affinity reagents specifically detect expression of all twelve of said genes.

5. A kit in accordance with claim 1 , wherein said affinity reagents specifically detect protein expression products of said genes.

6. A kit in accordance with claim 1 , wherein said affinity reagents specifically detect RNA transcription from said genes.

7. A kit in accordance with claim 1 , wherein said set of affinity reagents are chosen so as to specifically detect expression of at least nine of said group of genes.

8. A kit in accordance with claim 1 , wherein said set of affinity reagents contains fewer than 101 affinity reagents.

9. A kit for determining expression of at least six genes selected from the group consisting of JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, comprising:

a set of affinity reagents to specifically detect expression of said at least six genes, wherein said set of affinity reagents contains fewer than 626 affinity reagents; and

a substrate on which each of said affinity reagents are physically immobilized at a particular predefined position.

10. The kit of claim 9 , further comprising at least one signal producing system that, used in conjunction with at least one of said affinity reagents, generates a signal if said affinity reagent binds to a marker of expression of the gene for which said reagent is specific, the presence of said signal indicating expression of said gene or the level of said signal correlating to the level of expression of said gene.

11. A kit in accordance with claim 9 , wherein said set of affinity reagents contains fewer than 101 affinity reagents.

12. A kit in accordance with claim 9 , wherein said set of affinity reagents further includes affinity reagents to detect expression of control genes.

13. A kit in accordance with claim 9 , for detecting all of the genes JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, wherein said set of affinity reagents specifically detect expression of all twelve of said genes.

14. A kit in accordance with claim 9 , wherein said affinity reagents specifically detect protein expression products of said genes.

15. A kit in accordance with claim 9 , wherein said affinity reagents specifically detect RNA transcription from said genes.

16. A kit in accordance with claim 9 , wherein said set of affinity reagents are chosen so as to specifically detect expression of at least seven of said group of genes.

17. A kit for determining expression of at least seven genes selected from the group consisting of JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, comprising:

a set of affinity reagents to specifically detect expression of said at least seven genes, wherein said set of affinity reagents contains fewer than 2,501 affinity reagents; and

at least one signal producing label attached directly or indirectly to the affinity reagent, said signal producing label being selected from the group consisting of a radioactive, enzymatic, hapten, reporter dye or fluorescent label.

18. A kit in accordance with claim 17 , wherein said set of affinity reagents further includes affinity reagents to detect expression of control genes.

19. A kit in accordance with claim 17 , for detecting all of the genes JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, wherein said set of affinity reagents specifically detect expression of all twelve of said genes.

20. A kit in accordance with claim 17 , wherein said set of affinity reagents are chosen so as to specifically detect expression of at least nine of said group of genes.

21. A kit in accordance with claim 17 , wherein said set of affinity reagents contains fewer than 101 affinity reagents.

22. A kit in accordance with claim 17 , wherein said affinity reagents specifically detect protein expression products of said genes.

23. A kit in accordance with claim 17 , wherein said affinity reagents specifically detect RNA transcription from said genes.

24. A kit for determining expression of at least six genes selected from the group consisting of JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, comprising:

a set of affinity reagents to specifically detect expression of said at least six genes, wherein said set of affinity reagents contains fewer than 626 affinity reagents; and

at least one signal producing label attached directly or indirectly to the affinity reagent, said signal producing label being selected from the group consisting of a radioactive, enzymatic, hapten, reporter dye or fluorescent label.

25. A kit in accordance with claim 24 , wherein said set of affinity reagents further includes affinity reagents to detect expression of control genes.

26. A kit in accordance with claim 24 , for detecting all of the genes JUNB, KLF4, FOXH1, FOS, CLDN4, PADI4, B3GNT5, CDC7, PANK1, UNG, CBR3, and ATF3, wherein said set of affinity reagents specifically detect expression of all twelve of said genes.

27. A kit in accordance with claim 24 , wherein said affinity reagents specifically detect protein expression products of said genes.

28. A kit in accordance with claim 24 , wherein said set of affinity reagents are chosen so as to specifically detect expression of at least seven of said group of genes.

29. A kit in accordance with claim 24 , wherein said set of affinity reagents are chosen so as to specifically detect expression of at least nine of said group of genes.

30. A kit in accordance with claim 24 , wherein said set of affinity reagents contains fewer than 101 affinity reagents.

31. A kit in accordance with claim 24 , wherein said affinity reagents specifically detect RNA transcription from said genes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 5, 2016
From: NEW YORK UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039073/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2013
From: WILSON, ELAINE LYNETTE; OSSOWSKI, LILIANA; SMITH, PHILLIP ROSS
To: NEW YORK UNIVERSITY
Reel/Frame 030410/0514 →
Continuity (1)
Provisional Application 61610802 · Mar 14, 2012